Patent details

EP2175861 Title: Pharmaceutical combination of naproxen with 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1

Basic Information

Publication number:
EP2175861
PCT Application Number:
PCT/JP/2008/062437
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087780185
PCT Publication Number:
WO/2009/005172
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical combination of naproxen with 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1
French Title of Invention:
Combinaison pharmaceutique de naproxène et de 13,14-dihydro-15-céto-16,16-difluoro-18-méthyl-prostaglandine E1
German Title of Invention:
Pharmazeutische Kombination von Naproxen und 13,14-Dihydro-15-Keto-16,16-Difluor-18-Methyl-Prostaglandin E1
SPC Number:

Dates

Filing date:
03/07/2008
Grant date:
20/08/2014
EP Publication Date:
20/08/2014
PCT Publication Date:
08/01/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/04/2010
EP B1 Publication Date:
20/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/07/2015
Expiration date:
03/07/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/07/2008
 
 

Name:
Sucampo AG
Address:
Baarerstrasse 22, 6300 Zug, Switzerland (CH)

Inventor

Name:
UENO Ryuji
Address:
United States (US)

Priority

1

Priority Number:
929557 P
Priority Date:
03/07/2007
Priority Country:
United States (US)

2

Priority Number:
37517
Priority Date:
18/03/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 45/06;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages